PAR paradigm biopharmaceuticals limited..

PAR Investor Meeting - Questions from HC, page-58

  1. 2,203 Posts.
    lightbulb Created with Sketch. 595
    This worked out well.

    No clarity on peer review, patents, TGA Provisional Approval, lack of public KOL endorsement, lack of institutional investment, if they will guzump all the timelines to push for a DMOAD label before NDA whilst there is absolutely no clear pathway.

    I could say I told you so, so I will.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
41.0¢
Change
0.000(0.00%)
Mkt cap ! $162.9M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 2500 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
38.5¢ 12500 2
View Market Depth
Last trade - 09.48am 18/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.